According to a study presented at the ESC Congress 2019, patients who stop taking statins are at similar risk to those who never start. Statins, a class of drugs that reduce illness and mortality in those who are at high risk of cardiovascular disease can also prove effective for those with the peripheral arterial disease even if they start its medication late after diagnosis. According to the study presented today at the 'ESC Congress 2019' patients who stop the drug are at similar risk to those who never start. The research showed the importance of starting and adhering to lifelong medication, preferably at a high dose.
Around 200 million people worldwide have peripheral arterial disease (PAD), a condition in which arteries in the legs are clogged. This restricts blood flow to the legs and raises the chances of stroke and heart attack. Around 30 per cent of patients have pain and…
